Protamines: Clinical Trials

11 trials of Protamines, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 2 recruiting, 2 unknown. 4 Not applicable, 4 Phase 4, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable4Unknown 2, Completed 1, Recruiting 1
Phase 44Completed 4
Phase 32Completed 1, Recruiting 1

Follow Protamines: new trials by email Literature Review of Protamines trials Research Report on Protamines

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dose for Reversal of Heparin After Cardiopulmonary Bypass
Protamine sulfate - Open Heart Surgery
Not applicableRecruitingSohag University1952026-03-012026-05-05
Antagonization of Heparin With Protamine Sulfate After TAVI
Antagonization of heparin with protamine sulfate - Aortic Valve Stenosis, Heart Valve Diseases
Phase 3RecruitingAssistance Publique - Hôpitaux de Paris9402025-05-252025-08-22
Impact of Protamine Dose Reduction on Platelet Aggregation After Extracorporeal Circulation for Minimally Invasive Aortic Valve Replacement Surgery
Low dose protamine - Protamine Dose, Protamine Adverse Reaction
Not applicableUnknownUniversity of Liege502024-03-152024-02-12
Routine Versus Selective Protamine Administration to Reduce Bleeding Complications After Transcatheter Aortic Valve Implantation (POPular ACE TAVI)
Protamine sulfate - Aortic Valve Stenosis
Phase 4CompletedSt. Antonius Hospital10002023-11-012026-05-20
Optimal Protamine Dosing for Heparin Reversal Following Cardiopulmonary Bypass
Protamine fixed dose, Protamine ratio dose - Coagulation; Intravascular
Phase 4CompletedUniversity of Miami1302022-06-282024-08-13
Systematic Evaluation of Protamine Doze in Cardiac Surgery
Protamine Sulfate - Cardiac Surgery With Cardiopulmonary Bypass
Not applicableUnknownLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1002018-09-202018-12-31
Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation
Protamine Sulfate - Atrial Fibrillation, Catheter Ablation
Phase 4CompletedUniversity of Michigan1532017-03-232018-10-23
Protamine Sulfate During Transcatheter Aortic Valve Implantation
Protamine sulfate, 0.9% NaCl - Aortic Valve Stenosis
Phase 4CompletedMedical University of Warsaw1002016-12-012020-10-22
Serum Tryptase Levels During Cardiac Surgery, Diagnosis and Treatment Decisions for Allergic Reactions
protamine - Protamine Allergy, Protamine Adverse Reaction
CompletedMustafa Kemal University302016-01-012017-03-22
Cardiac Surgery: In Vivo Titration of Protamine
Titration protamine, Standard administration of protamine - Bleeding
Not applicableCompletedMontreal Heart Institute1382008-06-012011-08-25
Comparing Angiomax to Heparin With Protamine Reversal in Patients OPCAB
Bivalirudin, Heparin, Protamine - Cardiac Surgery, Coronary Artery Bypass Surgery
Phase 3CompletedThe Medicines Company1502003-08-012011-11-10

Conditions studied

Aortic Valve Stenosis (3)  ·  Hemorrhage (2)  ·  Anaphylaxis (1)  ·  Atrial Fibrillation (1)  ·  Heart Valve Diseases (1)  ·  Hypersensitivity (1)  ·  Hypotension (1)  ·  Postoperative Hemorrhage (1)  ·  Thrombosis (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1)  ·  Medical University of Warsaw (1)  ·  Montreal Heart Institute (1)  ·  Mustafa Kemal University (1)  ·  Sohag University (1)  ·  St. Antonius Hospital (1)  ·  The Medicines Company (1)  ·  University of Liege (1)  ·  University of Miami (1)  ·  University of Michigan (1)

Countries

United States (3)  ·  Canada (2)  ·  Belgium (1)  ·  Egypt (1)  ·  France (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Turkey (Türkiye) (1)

Top investigators

Andrew Sternlicht, MD (1)  ·  Antoine G Rochon (1)  ·  Asmaa S Farghaly, MD (1)  ·  Hakan Oral, MD (1)  ·  Menekse Oksar, M.D. (1)  ·  Michael Fabbro, DO (1)

Results publications

PMID 12960536, PMID 18005384, PMID 22898522, PMID 23236027, PMID 23583252, PMID 24682842, PMID 25070464, PMID 26139739, PMID 34292562, PMID 36471142, PMID 41177203

NIH funding

2023 (1)